Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
92,298,944
-
Total 13F shares
-
98,257,416
-
Share change
-
+1,567,553
-
Total reported value
-
$6,229,471,990
-
Put/Call ratio
-
86%
-
Price per share
-
$63.41
-
Number of holders
-
309
-
Value change
-
+$94,500,600
-
Number of buys
-
158
-
Number of sells
-
155
Institutional Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) as of Q3 2024
As of 30 Sep 2024,
Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) was held by
309 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,257,416 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock, Inc., T. Rowe Price Investment Management, Inc., VIKING GLOBAL INVESTORS LP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, JPMORGAN CHASE & CO, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, and Point72 Asset Management, L.P..
This page lists
307
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.